CHMP begins rolling review of Gilead’s remdesivir
It is expected that the move will allow the EMA to complete its assessment of the drug significantly earlier than with a regular evaluation procedure
Read More
Tag: corona
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
